Patent Assignment
Reel/Frame 016914/0056
Release of Security Interest Under the Amended and Restated Credit Agreement
Recorded: 2005-12-19
Pages: 3
Assignor
DLJ CAPITAL FUNDING, INC. AS ADMINISTRATIVE AGENT
Executed: 2004-09-10
Assignee
SHIRE LABORATORIES, INC.
1550 EAST GUDE DRIVE, ROCKVILLE, MARYLAND, 20850
Covered Properties
(25)
Production of Butyrylcholinesterase
Patent:
5,272,080 →
Application:
07/657,089 →
Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine
Patent:
5,326,570 →
Application:
07/734,541 →
Hydrophobic Drug Delivery Systems
Patent:
5,430,021 →
Application:
08/210,014 →
Sustained-Release Drug Delivery System
Patent:
5,484,608 →
Application:
08/218,757 →
Multilamellar Drug Delivery Systems
Patent:
5,447,729 →
Application:
08/224,340 →
Emulsified Drug Delivery Systems
Patent:
5,952,004 →
Application:
08/424,521 →
Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine
Patent:
5,912,013 →
Application:
08/426,394 →
Oral Insulin Delivery
Patent:
5,824,638 →
Application:
08/446,399 →
Oral Acyclovir Delivery
Patent:
5,883,103 →
Application:
08/475,036 →
Emulsified Drug Delivery System
Patent:
5,897,876 →
Application:
08/879,994 →
Soluble Form Osmotic Dose Delivery System
Patent:
6,110,498 →
Application:
08/954,947 →
Oral Induction of Tolerance to Parenterally Administered Non-Autologous Polypeptides
Patent:
5,948,407 →
Application:
09/045,886 →
Solid Solution Beadlet
Oral Pulsed Dose Drug Delivery System
Solid Oral Dosage Form
Patent:
6,793,934 →
Application:
09/457,248 →
Rapid Immediate Release Oral Dosage Form
Patent:
6,384,020 →
Application:
09/611,098 →
Soluble form osmotic dose delivery system
Patent:
6,284,276 →
Application:
09/613,202 →
Soluble form osmotic dose delivery system
Patent:
6,361,796 →
Application:
09/634,224 →
Oral Pulsed Dose Drug Delivery System
Patent:
6,605,300 →
Application:
09/807,462 →
Soluble Form Osmotic Dose Delivery System
Soluble Form Osmotic Dose Delivery System
Oral pulsed dose drug delivery system
Application:
10/758,417 →
Publication:
US 2004/0219213
Oral Pulsed Dose Drug Delivery System
Patent:
41,148 →
Application:
11/091,010 →
Oral Pulsed Dose Drug Delivery System
Patent:
42,096 →
Application:
11/091,011 →
Single Phase Solid Solution Beadlet
Application:
60/059,408 →
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 5, 2001
From: PINKETT, JILL E.
To: SHIRE LABORATORIES, INC.
Reel/Frame 012231/0362 →
Assignment of Assignor's Interest
Feb 25, 2002
From: BURNSIDE, BETH A.; RUDNIC, EDWARD M.; FLANNER, HENRY H.; WASSINK, SANDRA E.
To: SHIRE LABORATORIES, INC.
Reel/Frame 012651/0333 →
Assignment of Assignor's Interest
May 10, 2006
From: SHIRE LABORATORIES, INC
To: SUPERNUS PHARMACEUTICALS, INC
Reel/Frame 017596/0304 →
Merger
Dec 18, 2006
From: SHIRE LABORATORIES, INC.
To: SHIRE LLC
Reel/Frame 018648/0711 →
Merger
Dec 19, 2006
From: SHIRE LABORATORIES, INC.
To: SHIRE LLC
Reel/Frame 018654/0073 →
Merger
Dec 21, 2006
From: SHIRE LABORATORIES INC
To: SHIRE LLC
Reel/Frame 018668/0006 →
Merger
Feb 23, 2007
From: SHIRE LABORATORIES, INC.
To: SHIRE LLC
Reel/Frame 019147/0302 →
License
Oct 30, 2009
From: SHIRE LABORATORIES INC.
To: ENDO PHARMACEUTICALS SOLUTIONS INC. FORMERLY INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 023449/0563 →
Corrective Assignment to Correct the Incorrect Patent Number 6890970 Previously Recorded on Reel 023449 Frame 0563. Assignor(S) Hereby Confirms the License.
Dec 14, 2009
From: SHIRE LABORATORIES INC.
To: ENDO PHARMACEUTICALS SOLUTIONS INC. FORMERLY INDEVUS PHARMACEUTICALS INC.
Reel/Frame 023639/0961 →
Confirmatory Grant of Security Interest in United States Patents (Exclusively Licensed Patents)
Feb 13, 2010
From: ENDO PHARMACEUTICALS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 023928/0628 →
Confirmatory Grant of Security Interest in United States Patents (Exclusively Licensed Patents)
Dec 9, 2010
From: ENDO PHARMACEUTICALS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 025456/0172 →
Release of Security Interest Recorded at Reel/Frame 23928/628
Dec 9, 2010
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 025456/0778 →
Security Interest in Exclusively Licensed Patents
Jul 8, 2011
From: ENDO PHARMACEUTICALS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026561/0978 →
Release of Security Interest in Exclusively Licensed Patents Recorded at Reel/Frame 25456/172
Jul 12, 2011
From: JPMORGAN CHASE BANK N.A., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 026577/0357 →
Security Agreement
Jun 7, 2013
From: SUPERNUS PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 030571/0679 →
Release of Patent Security Interest in Exclusively Licensed Patents
Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 032380/0157 →
Grant of Security Interest in Licensed Patents
Mar 20, 2014
From: ENDO PHARMACEUTICALS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0620 →
Corrective Assignment to Correct the Name of Receiving Party in Release of Patent Security Interest in Exclusively Licensed Patents Previously Recorded on Reel 032380 Frame 0157. Assignor(S) Hereby Confirms the Release of Security Interest in Exclusively Licensed Patents..
Mar 24, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 032513/0255 →
Release of Security Interest
Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ENDO PHARMACEUTICALS, INC.; ENDO PHARMACEUTICALS SOLUTIONS, INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
Reel/Frame 042362/0001 →
Release of Security Interest
Nov 30, 2017
From: U.S. BANK NATIONAL ASSOCIATION
To: SUPERNUS PHARMACEUTICALS, INC.
Reel/Frame 044552/0694 →